Consequences of delayed diagnosis of rocky mountain spotted fever in children - West Virginia, Michigan, Tennessee, and Oklahoma, May-July 2000

JAMA

Volumn 284, Issue 16, 2000, Pages 2049-2050

  Minnich, L ^a   McJunkin, J E ^a   Bixler, D ^a   Slemp, C ^a   Haddy, L ^a   Busse, F ^a   Harrison, M ^a   Stobierski, M G ^a   Boulton, M L ^a   Jones, T ^a   Moore, W ^a   Barton, P ^a   Bradley, K ^a   Crutcher, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; DOXYCYCLINE; PENICILLIN DERIVATIVE; SULFANILAMIDE DERIVATIVE; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC THERAPY; CASE REPORT; CHILD; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CONTROL; DISEASE COURSE; DRUG CHOICE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; EARLY DIAGNOSIS; FATALITY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PREVALENCE; PRIORITY JOURNAL; RASH; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; SEROLOGY; SHORT SURVEY; TICK; TOOTH COLOR; UNITED STATES; ARTICLE; DIAGNOSTIC ERROR; INFANT; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FATAL OUTCOME; HUMANS; INFANT; MICHIGAN; OKLAHOMA; ROCKY MOUNTAIN SPOTTED FEVER; TENNESSEE; WEST VIRGINIA;

EID: 0034715406     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.16.2049     Document Type: Short Survey

References (0)